Ee Ting Ng
Directeur/Membre du Conseil chez Invitrocue Pte Ltd.
Profil
Ee Ting Ng is a Non-Executive Director at Invitrocue Pte Ltd.
She previously worked as a Non-Executive Director at Invitrocue Ltd.
from 2015 to 2019 and as a Director at BPH Global Ltd.
from 2018 to 2020.
Postes actifs de Ee Ting Ng
| Sociétés | Poste | Début |
|---|---|---|
Invitrocue Pte Ltd.
 Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ee Ting Ng
| Sociétés | Poste | Fin |
|---|---|---|
| BPH GLOBAL LTD | Directeur/Membre du Conseil | 31/03/2020 |
| INVITROCUE LIMITED | Directeur/Membre du Conseil | 15/10/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BPH GLOBAL LTD | Health Technology |
| Entreprise privées | 2 |
|---|---|
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Health Technology |
